Page last updated: 2024-10-23

bromhexine and Nerve Pain

bromhexine has been researched along with Nerve Pain in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Research Excerpts

ExcerptRelevanceReference
"Oxaliplatin (a single intraperitoneal dose of 10 mg/kg) induced tactile allodynia and cold hyperalgesia in CD-1 mice and the effectiveness of single-dose or repeated-dose bromhexine and ambroxol to attenuate pain hypersensitivity was assessed in von Frey and cold plate tests."3.96Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies. ( Fijałkowski, Ł; Furgała-Wojas, A; Kowalska, M; Nowaczyk, A; Sałat, K, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Furgała-Wojas, A1
Kowalska, M1
Nowaczyk, A1
Fijałkowski, Ł1
Sałat, K1

Other Studies

1 other study available for bromhexine and Nerve Pain

ArticleYear
Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies.
    Current drug metabolism, 2020, Volume: 21, Issue:7

    Topics: Analgesics; Animals; Antineoplastic Agents; Bromhexine; Cold Temperature; Drug Repositioning; Humans

2020